Breast cancer is a leading cause of illness and death among women in the United States, being the second most common cancer after non-melanoma skin cancer. It is also the [...]

There is a growing national demand to demonstrate quality of care, efficacious clinical outcomes and evidence based practice. Enhanced by Center for Medicare/Medicaid S [...]

Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor in adults. Owing to a high level of disease heterogeneity and common recurrence, 5-year surviv [...]

Dermoid cysts/sinuses (DCS) are congenital masses occurring along lines of embryonic fusion. Midline DCS carry a risk of intracranial extension. Pre-operative CT or MRI a [...]

Neurofibromatosis type 1 (NF1) is a genetically determined neurodevelopmental disorder and tumor syndrome with an incidence of approximately 1/3000 live births. A progre [...]

Administration of chemotherapy via intra-arterial (IA) route results in a higher concentration of targeted chemotherapy against resilient brain malignancies with a decrea [...]

Tumors overexpressing the HER2 oncogene account for around 20% of breast cancer cases and are associated with aggressive disease. These tumors generally originate from a [...]

Malignant solid tumors account for approximately 30% of childhood cancers (1,) most commonly Wilms tumor, Hepatoblastoma, and Neuroblastoma. Financial hardship is a compr [...]

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are the most common form of neuroendocrine neoplasia, but there is no current consensus for the sequencing of appr [...]